These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17825958)

  • 1. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds.
    Walker J; Ghosh S; Pagnon J; Colantoni C; Newbold A; Zeng W; Jackson DC
    Vaccine; 2007 Oct; 25(41):7111-9. PubMed ID: 17825958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35.
    Jung MJ; Moon YC; Cho IH; Yeh JY; Kim SE; Chang WS; Park SY; Song CS; Kim HY; Park KK; McOrist S; Choi IS; Lee JB
    J Vet Sci; 2005 Mar; 6(1):21-4. PubMed ID: 15785119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
    Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
    Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs.
    Yu M; Zeng W; Pagnon J; Walker J; Ghosh S; Wang LF; Jackson DC
    Vaccine; 2005 Aug; 23(37):4589-97. PubMed ID: 15927323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus.
    Ghosh S; Walker J; Jackson DC
    Immunology; 2001 Sep; 104(1):58-66. PubMed ID: 11576221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH.
    Zeng W; Gauci S; Ghosh S; Walker J; Jackson DC
    Vaccine; 2005 Aug; 23(35):4427-35. PubMed ID: 15919140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity of recombinant and dimeric gonadotrophin-releasing hormone vaccines incorporating a T-helper epitope and GnRH or repeated GnRH units.
    Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H
    J Immunol Methods; 2004 Jun; 289(1-2):111-22. PubMed ID: 15251417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function.
    Zeng W; Pagnon J; Jackson DC
    Mol Immunol; 2007 Jul; 44(15):3724-31. PubMed ID: 17512595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines.
    Ghosh S; Jackson DC
    Int Immunol; 1999 Jul; 11(7):1103-10. PubMed ID: 10383943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)--a histological comparison in male animals.
    Ferro VA; Khan MA; McAdam D; Colston A; Aughey E; Mullen AB; Waterston MM; Harvey MJ
    Vet Immunol Immunopathol; 2004 Sep; 101(1-2):73-86. PubMed ID: 15261694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility.
    Khan MA; Ogita K; Ferro VA; Kumasawa K; Tsutsui T; Kimura T
    Vaccine; 2008 Mar; 26(10):1365-74. PubMed ID: 18262690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo.
    Khan MA; Ferro VA; Koyama S; Kinugasa Y; Song M; Ogita K; Tsutsui T; Murata Y; Kimura T
    Vaccine; 2007 May; 25(18):3544-53. PubMed ID: 17316929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.
    Chua BY; Zeng W; Lau YF; Jackson DC
    Vaccine; 2007 Jan; 25(1):92-101. PubMed ID: 17055123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in contraceptive vaccine development: a mini-review.
    Naz RK; Gupta SK; Gupta JC; Vyas HK; Talwar AG
    Hum Reprod; 2005 Dec; 20(12):3271-83. PubMed ID: 16113040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of different presentation strategies for an HIV peptide immunogen.
    Cruz LJ; Iglesias E; Aguilar JC; González LJ; Reyes O; Albericio F; Andreu D
    Bioconjug Chem; 2004; 15(1):112-20. PubMed ID: 14733590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.
    Immonen AK; Taivainen AH; Närvänen AT; Kinnunen TT; Saarelainen SA; Rytkönen-Nissinen MA; Virtanen TI
    Immunology; 2007 Jan; 120(1):38-46. PubMed ID: 17233739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant.
    Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H; Roque RS
    Vaccine; 2005 Sep; 23(40):4834-43. PubMed ID: 15996796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.
    Talwar GP; Raina K; Gupta JC; Ray R; Wadhwa S; Ali MM
    Vaccine; 2004 Sep; 22(27-28):3713-21. PubMed ID: 15315851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.
    Xu J; Zhu Z; Wu J; Liu W; Shen X; Zhang Y; Hu Z; Zhu D; Roque RS; Liu J
    Cancer Lett; 2008 Feb; 259(2):240-50. PubMed ID: 18039558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.